WestEnd Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
WestEnd Advisors's AMGN Position: Q3 2026 in Review
WestEnd Advisors held its Amgen (AMGN) position steady in Q3 2026 at 48 shares worth $20.2K. The position accounts for ﹤0.01% of the portfolio, ranked #93.
WestEnd Advisors first reported a position in AMGN in Q2 2013 and has held it in 20 quarters since. The position peaked at $80.3M in Q3 2013. 2,024 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- WestEnd Advisors held 48 shares of Amgen worth $20.2K as of Q3 2026.
- WestEnd Advisors left its Amgen share count unchanged in Q3 2026.
- Amgen made up ﹤0.01% of WestEnd Advisors's portfolio in Q3 2026, its #93 holding.
- WestEnd Advisors first reported a position in Amgen in Q2 2013 and has held it in 20 quarters since.
- WestEnd Advisors's Amgen position peaked at $80.3M in Q3 2013.
- 2,024 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on WestEnd Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.